MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$807K
Net Income
-$9,370K
Net Profit Margin
-1161.09%
EPS
-$0.01
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and other
807
494
672
200
Research and development
5,705
4,858
5,554
7,450
General and administrative
6,707
6,536
8,622
7,070
Total operating costs and expenses
12,412
11,394
14,176
14,520
Loss from operations
-11,605
-10,900
-13,504
-14,320
Settlement gain
-
2,250
-
-
Change in fair value of derivative liabilities
-
9,416
1,177
-3,332
Change in fair value of share payable
64
201
-33
-118
Change in fair value of convertible notes
6,432
5,235
19,559
-15
Loss from extinguishment of debt
-2,180
-4,756
-1,595
-4,004
Loss from issuance of debt
-
-738
-1,100*
-1,611
Inducement expense
-
87
-
-
Interest expense
1,809
2,346
2,646
2,621
Foreign currency transaction gain (loss)
-123
-1,344
-1,007*
-808
Total other income (expense)
2,384
7,831
14,355
-12,509
Loss before income taxes
-
-
1,254*
-
Income tax benefit
-
-
-134*
-
Net gain
-9,221
-3,069
1,388
-26,829
Deemed dividend related to warrant modifications
332
331
137
353
Net gain attributable to common stockholders
-9,553
-3,400
1,251
-27,182
Foreign currency translation adjustment
-183
-496
-292
-632
Total comprehensive gain
-9,370
-2,904
1,543
-26,550
Basic EPS
-0.01
0
0
-0.02
Diluted EPS
-0.01
0
0
-0.02
Basic Average Shares
1,642,439,000
1,584,843,000
5,822,362,227
1,492,079
Diluted Average Shares
1,642,439,000
1,584,843,000
5,822,362,227
1,492,079
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
NWBO Income Statement Sankey Diagram
Sankey diagram visualizing NWBO income statement for the period
Total comprehensive
gain
-$9,370K
(51.16%↑ Y/Y)
Foreign currency
translation adjustment
-$183K
(-105.63%↓ Y/Y)
Net gain
attributable to common...
-$9,553K
(40.06%↑ Y/Y)
Change in fair value of
convertible notes
$6,432K
(168.90%↑ Y/Y)
Change in fair value of
share payable
$64K
(126.67%↑ Y/Y)
Net gain
-$9,221K
(40.04%↑ Y/Y)
Deemed dividend
related to warrant...
$332K
(-40.71%↓ Y/Y)
Total other income
(expense)
$2,384K
(498.00%↑ Y/Y)
Loss from
extinguishment of debt
-$2,180K
(51.73%↑ Y/Y)
Interest expense
$1,809K
(-0.93%↓ Y/Y)
Foreign currency
transaction gain (loss)
-$123K
(-103.38%↓ Y/Y)
Loss from operations
-$11,605K
(21.48%↑ Y/Y)
Research and other
$807K
(516.03%↑ Y/Y)
Total operating costs
and expenses
$12,412K
(-16.75%↓ Y/Y)
General and
administrative
$6,707K
(-10.33%↓ Y/Y)
Research and development
$5,705K
(-23.22%↓ Y/Y)
Buy us a coffee
NORTHWEST BIOTHERAPEUTICS INC (NWBO)
NORTHWEST BIOTHERAPEUTICS INC (NWBO)